BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PR, PGR, progesterone receptor AND Treatment
606 results:

  • 1. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
    Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
    Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
    BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
    Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
    Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
    Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
    Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
    Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
    Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
    Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
    Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
    Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
    Kikuchi K; Ogawa M; Sasaki A
    J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
    Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
    EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Validity assessment of the POLARS score tool in the prediction of post rectal cancer surgery LARS score in a population-based Swedish cohort.
    Rethy B; Nordenvall C; Pieniowski E; Jansson-Palmer G; Johar A; Lagergren P; Abraham-Nordling M
    BMJ Open Gastroenterol; 2024 Jan; 11(1):. PubMed ID: 38199776
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
    Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
    Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics.
    Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J
    PeerJ; 2023; 11():e16631. PubMed ID: 38144182
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
    Li M; Zheng W
    Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
    Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
    Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Anxiety is Associated With Geriatric Assessment Impairments and Reduced Quality of Life Among Older Adults With colorectal cancer: Results From the CARE Registry.
    Hess DL; Fowler ME; Harmon C; Giri S; Williams GR
    Clin Colorectal Cancer; 2023 Dec; 22(4):383-389. PubMed ID: 37743126
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.
    Lei Y; Cao P; Zheng X; Wei J; Cheng M; Liu M
    Cancer Med; 2023 Oct; 12(19):19838-19849. PubMed ID: 37732493
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
    Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
    BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hormone receptor-Positive Breast cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3.
    Kaplan HG; Whiteaker JR; Nelson B; Ivey RG; Lorentzen TD; Voytovich U; Zhao L; Corwin DJ; Resta R; Paulovich AG
    J Natl Compr Canc Netw; 2023 Aug; 21(11):1110-1116. PubMed ID: 37643636
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Socioeconomic factors and colorectal cancer incidence, stage and quality of care in Denmark during the COVID-19 pandemic.
    Weinberger Rosen A; Jensen H; Olesen TB; Møller H; Jensen JW; Gögenur I
    Cancer Epidemiol; 2023 Oct; 86():102447. PubMed ID: 37633057
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.